Moreover, a reduction in nuclear NF-κB p65 protein was observed in Ru/5-FU-treated CRC HCT116 cells, indicating that this compound interferes with NF-κB p65 signaling (Fig. 3E). This evidence concerns the gene NFKB1 and colorectal carcinoma.